FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367721038> ?p ?o ?g. }

• W4367721038 abstract "<h3>Background and Importance</h3> Pharmacovigilance has an essential role in monitoring outpatient treatments. As healthcare professionals we have the responsibility to report suspected adverse drug reactions (ADRs), so these data can be analysed by pharmacovigilance centres to determine the causality of possible unknown risks or changes in the severity and frequency of those already known. In the last decade, the rise of biological therapies as standard treatment in a huge array of pathologies in outpatient practices has led us to focus our project on them. <h3>Aim and Objectives</h3> Analyse suspected ADRs reported to the National Pharmacovigilance System of the Agency of Medicines and Health Products (AMHPS), from the outpatient department in a central Hospital Pharmacy. <h3>Material and Methods</h3> Single-centre observational retrospective study of suspected adverse reactions reported over a three-month period [July 2022 – September 2022]. The following data were collected: age, sex, treatment, indication, date of initiation, ADRs type and duration. Results were compared with the AMHPS National database, which is updated every 3 months. <h3>Results</h3> In these months, we reported seven suspected ADRs. Most of them were reported in women(85,8%), with a mean age of 49,6 years(32–64). The biological therapies suspected of triggering ADRs were adalimumab, sarilumab, etanercept, abatacept, erenumab and galcanezumab. The adverse reactions reported were mostly related to the presence of infections(42,8%), followed by muscle disorders(28,6%), nausea(14,3%) and neutropenia(14,3%). Among the biological therapies used, the one associated with the highest number of notifications was sarilumab(28,6%) and the most frequent indication was rheumatoid arthritis(57,14%). <h3>Conclusion and Relevance</h3> Comparing the results with the AMHPS database, in our population we observe a greater number of notifications for sarilumab, being the one with the fewest national notifications, probably related to its recent authorisation and not being used in first-line treatments. On the other hand, in the overall number of national ADRs notifications, infections are not the most frequent ADR, being in the first place musculoskeletal and gastrointestinal disorders. It is important to be aware of the role of pharmacists and all healthcare professionals in contributing to the detection of ADRs. Collecting this data and taking a global view of it by healthcare institutions allows to improve safety in outpatient treatments. <h3>References and/or Acknowledgements</h3> <h3>Conflict of Interest</h3> No conflict of interest" @default.
• W4367721038 created "2023-05-04" @default.
• W4367721038 creator A5006709003 @default.
• W4367721038 creator A5006840452 @default.
• W4367721038 creator A5017833801 @default.
• W4367721038 creator A5029135402 @default.
• W4367721038 creator A5033055030 @default.
• W4367721038 creator A5039838330 @default.
• W4367721038 creator A5051574160 @default.
• W4367721038 creator A5077404135 @default.
• W4367721038 date "2023-03-01" @default.
• W4367721038 modified "2023-10-17" @default.
• W4367721038 title "5PSQ-092 Pharmacovigilance of biological therapies from the outpatient department" @default.
• W4367721038 doi "https://doi.org/10.1136/ejhpharm-2023-eahp.450" @default.
• W4367721038 hasPublicationYear "2023" @default.
• W4367721038 type Work @default.
• W4367721038 citedByCount "0" @default.
• W4367721038 crossrefType "proceedings-article" @default.
• W4367721038 hasAuthorship W4367721038A5006709003 @default.
• W4367721038 hasAuthorship W4367721038A5006840452 @default.
• W4367721038 hasAuthorship W4367721038A5017833801 @default.
• W4367721038 hasAuthorship W4367721038A5029135402 @default.
• W4367721038 hasAuthorship W4367721038A5033055030 @default.
• W4367721038 hasAuthorship W4367721038A5039838330 @default.
• W4367721038 hasAuthorship W4367721038A5051574160 @default.
• W4367721038 hasAuthorship W4367721038A5077404135 @default.
• W4367721038 hasBestOaLocation W43677210381 @default.
• W4367721038 hasConcept C104863432 @default.
• W4367721038 hasConcept C126322002 @default.
• W4367721038 hasConcept C177713679 @default.
• W4367721038 hasConcept C187212893 @default.
• W4367721038 hasConcept C194828623 @default.
• W4367721038 hasConcept C197934379 @default.
• W4367721038 hasConcept C23131810 @default.
• W4367721038 hasConcept C2777226972 @default.
• W4367721038 hasConcept C2777575956 @default.
• W4367721038 hasConcept C2779134260 @default.
• W4367721038 hasConcept C2780132546 @default.
• W4367721038 hasConcept C512399662 @default.
• W4367721038 hasConcept C57658597 @default.
• W4367721038 hasConcept C71924100 @default.
• W4367721038 hasConceptScore W4367721038C104863432 @default.
• W4367721038 hasConceptScore W4367721038C126322002 @default.
• W4367721038 hasConceptScore W4367721038C177713679 @default.
• W4367721038 hasConceptScore W4367721038C187212893 @default.
• W4367721038 hasConceptScore W4367721038C194828623 @default.
• W4367721038 hasConceptScore W4367721038C197934379 @default.
• W4367721038 hasConceptScore W4367721038C23131810 @default.
• W4367721038 hasConceptScore W4367721038C2777226972 @default.
• W4367721038 hasConceptScore W4367721038C2777575956 @default.
• W4367721038 hasConceptScore W4367721038C2779134260 @default.
• W4367721038 hasConceptScore W4367721038C2780132546 @default.
• W4367721038 hasConceptScore W4367721038C512399662 @default.
• W4367721038 hasConceptScore W4367721038C57658597 @default.
• W4367721038 hasConceptScore W4367721038C71924100 @default.
• W4367721038 hasLocation W43677210381 @default.
• W4367721038 hasOpenAccess W4367721038 @default.
• W4367721038 hasPrimaryLocation W43677210381 @default.
• W4367721038 hasRelatedWork W2052000874 @default.
• W4367721038 hasRelatedWork W2390905470 @default.
• W4367721038 hasRelatedWork W24711590 @default.
• W4367721038 hasRelatedWork W2737526559 @default.
• W4367721038 hasRelatedWork W2755778884 @default.
• W4367721038 hasRelatedWork W2889865287 @default.
• W4367721038 hasRelatedWork W2965436229 @default.
• W4367721038 hasRelatedWork W2978616557 @default.
• W4367721038 hasRelatedWork W3096777956 @default.
• W4367721038 hasRelatedWork W2615182756 @default.
• W4367721038 isParatext "false" @default.
• W4367721038 isRetracted "false" @default.
• W4367721038 workType "article" @default.